Publication | Open Access
Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial
67
Citations
19
References
2022
Year
GlaxoSmithKline Biologicals; PATH's Malaria Vaccine Initiative.
| Year | Citations | |
|---|---|---|
Page 1
Page 1